Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma

Strahlentherapie und Onkologie

Volumn 183, Issue SUPPL. 2, 2007, Pages 16-18

  Eich, Hans Theodor ^a   Müller, Rolf Peter ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Combined modality treatment; Hodgkin's lymphoma; Involved field radiotherapy; Quality assurance

Indexed keywords

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONFERENCE PAPER; DIAGNOSTIC ERROR; DISEASE FREE SURVIVAL; EARLY DIAGNOSIS; HODGKIN DISEASE; HUMAN; METASTASIS; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; RECURRENT DISEASE; RISK FACTOR; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; COMBINED MODALITY THERAPY; DACARBAZINE; DOXORUBICIN; FOLLOW-UP STUDIES; FORECASTING; HODGKIN DISEASE; HUMANS; LYMPH NODES; NEOPLASM STAGING; PROSPECTIVE STUDIES; QUALITY ASSURANCE, HEALTH CARE; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME; VINBLASTINE;

EID: 37549053598     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-007-2007-4     Document Type: Conference Paper

References (15)

1. Pusey WA. Cases of sarcoma and of Hodgkin's disease treated by exposures of x-rays: a preliminary report. JAMA 1902;38:166-169.
2. Kaplan HS, Rosenberg SA. The management of Hodgkin's disease. Cancer 1975;36:796-803.
3. Peters M, Middlemiss K. A study of Hodgkin's disease treated by irradiation. Am J Roentgenol 1958;79:114-121.
4. Rosenberg SA, Kaplan HS. The evolution and summary results of the Stanford randomised clinical trials of the management of Hodgkin's disease: 1962-1984. Int J Radiat Oncol Biol Phys 1985;11:5-22.
5. Dühmke E, Franklin J, Pfreundschuh M, et al. Low-dose radiation is sufficient for the noninvolved extended field treatment in favorable early-stage Hodgkin's disease: long-term results of a randomized trial of radiotherapy alone. J Clin Oncol 2001;19(11):2905-14.
6. Müller R-P, Eich HT. The developement of quality assurance of radiotherapy within the German Hodgkin Study Group (GHSG) - Introduction, continuing work and results of the radiotherapy reference panel. Strahlenther Onkol 2005;181(9):557-566.
7. Groscu, A-L, Piert M, Weber WA, et al. Positron emission tomography for radiation treatment planning. Strahlenther Onkol 2005;181 (8): 483-499.
8. Dörr W, Köst K, Keinert K, et al. Early intestinal changes following abdominal radiotherapy comparison of endpoints. Strahlenther Onkol 2006;182(1):1-8.
9. Trott K-R, Kamprad F. Estimation of cancer risks from radiotherapy of benign diseases. Strahlenther Onkol 2006;182(8):431-436.
10. Bölling T, Schuck A, Rübe C, et al. Therapy-associated late effects after irradiation of malignant diseases in childhood and adolescence. Feasibility analyses of a prospective multicenter register study. Strahlenther Onkol 2006;182(8):443-449.
11. Engert A, Schiller P, Josting A, et al. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavourable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's lymphoma Study Group. J Clin Oncol 2003;21;19:3601-3608.
12. Eich HT, Haverkamp U, Engert A, et al. Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma - a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group (GHSG). Int J Radiat Oncol Biol Phys 2005;63(3):860-865.
13. Müller R-P, Eich HT. Current role of radiotherapy in the treatment of Hodgkin's disease. In: Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK (eds.). Update Principles and Practice of Radiation Oncology. Lippincott Williams & Wilkins 2005; Vol 6 Number 2:2-15.
14. Eich HT, Staar S, Gossmann A, et al. Centralized radiation oncological review of cross-sectional imaging of Hodgkin's disease leads to significant changes of the required involved field - results of a quality assurance program of the German Hodgkin Study Group (GHSG). Int J Radiat Oncol Biopl Phys 2004;58(4):1120-1126.
15. Eich HT, Hansemann K, Müller R-P. Behandlung früher Stadien des Hodgkin-Lymphoms unter dem Aspekt der Qualitätssicherung. Onkologe 2005;11:924-932.